|
US8563522B2
(en)
|
1997-07-08 |
2013-10-22 |
The Iams Company |
Method of maintaining and/or attenuating a decline in quality of life
|
|
AUPQ899700A0
(en)
|
2000-07-25 |
2000-08-17 |
Borody, Thomas Julius |
Probiotic recolonisation therapy
|
|
US7182943B2
(en)
*
|
2002-05-15 |
2007-02-27 |
UNIVERSITé LAVAL |
Method and system for modulation of microbial cell characteristics
|
|
EP1384483A1
(en)
*
|
2002-07-23 |
2004-01-28 |
Nestec S.A. |
Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
|
|
SE526711C2
(sv)
*
|
2003-01-31 |
2005-10-25 |
Probi Ab |
Nya stammar av Bifidobacterium med förmåga att överleva i magtarmkanalen och producera glutamin in vivo, samt kompositioner och användningar därav
|
|
US20040197304A1
(en)
|
2003-04-01 |
2004-10-07 |
The Procter & Gamble Company And Alimentary Health, Ltd. |
Methods of determining efficacy of treatments of inflammatory diseases of the bowel
|
|
EP2280286A1
(en)
*
|
2003-09-15 |
2011-02-02 |
Oklahoma Medical Research Foundation |
Method of using cytokine assays to diagnose, treat, and evaluate systemic lupus erythematosus
|
|
WO2005030230A1
(en)
*
|
2003-09-30 |
2005-04-07 |
Probiomics Limited |
Compositions and methods for treatment or prevention of psoriasis and related disorders
|
|
GB0323039D0
(en)
*
|
2003-10-01 |
2003-11-05 |
Danisco |
Method
|
|
AU2004275438B2
(en)
*
|
2003-10-01 |
2008-05-29 |
Commonwealth Scientific & Industrial Research Organisation |
Probiotic storage and delivery
|
|
US8871266B2
(en)
|
2003-10-01 |
2014-10-28 |
Commonwealth Scientific & Industrial Research Organisation |
Probiotic storage and delivery
|
|
US20090257993A1
(en)
|
2003-12-17 |
2009-10-15 |
M Rabet Laura |
Lactic Acid Producing Bacteria and Lung Function
|
|
US20050158294A1
(en)
|
2003-12-19 |
2005-07-21 |
The Procter & Gamble Company |
Canine probiotic Bifidobacteria pseudolongum
|
|
US7785635B1
(en)
|
2003-12-19 |
2010-08-31 |
The Procter & Gamble Company |
Methods of use of probiotic lactobacilli for companion animals
|
|
US8877178B2
(en)
|
2003-12-19 |
2014-11-04 |
The Iams Company |
Methods of use of probiotic bifidobacteria for companion animals
|
|
US8894991B2
(en)
|
2003-12-19 |
2014-11-25 |
The Iams Company |
Canine probiotic Lactobacilli
|
|
US20050152884A1
(en)
|
2003-12-19 |
2005-07-14 |
The Procter & Gamble Company |
Canine probiotic Bifidobacteria globosum
|
|
WO2005072718A1
(ja)
*
|
2004-01-28 |
2005-08-11 |
Kurume University |
乳清発酵物を含有する医薬組成物
|
|
JP2005247780A
(ja)
*
|
2004-03-05 |
2005-09-15 |
Masakazu Maruyama |
ウイルス性肝炎治療剤
|
|
ES2262418B1
(es)
*
|
2004-12-28 |
2007-11-01 |
Consejo Superior Investig. Cientificas |
Extractos proteicos con amplio espectro de actividad antibacteriana y cepas del genero bifidobacterium que los producen.
|
|
TW200700074A
(en)
*
|
2005-03-04 |
2007-01-01 |
Calpis Co Ltd |
Inducer of t cell apoptosis
|
|
WO2006097949A1
(en)
*
|
2005-03-16 |
2006-09-21 |
Actial Farmacêutica, Lda. |
Mixture of at least 6 species of lactic acid bacteria and/or bifidobacteria in the manufacture of sourdough
|
|
EP2308566B1
(en)
|
2005-04-08 |
2017-07-05 |
The Procter and Gamble Company |
Use of orally administered probiotic bifidobacteria for human beauty benefits
|
|
AU2011205121B2
(en)
*
|
2005-04-08 |
2012-07-05 |
Alimentary Health Ltd |
Method of use of orally administered probiotic bifidobacteria for human beauty benefits
|
|
DE602006006997D1
(de)
*
|
2005-05-16 |
2009-07-09 |
Univ Liege |
Probiotische bifidobacterium arten
|
|
JP4938006B2
(ja)
|
2005-05-31 |
2012-05-23 |
ザ・アイムス・カンパニー |
ネコ科動物プロバイオティク・ビフィドバクテリア
|
|
EP2261323A1
(en)
|
2005-05-31 |
2010-12-15 |
The Iams Company |
Feline probiotic lactobacilli
|
|
US20090257995A1
(en)
|
2005-11-18 |
2009-10-15 |
Idemitsu Kosan Co., Ltd. |
Harmful bacterium control agent containing bacillus thuringiensis
|
|
GB0524103D0
(en)
*
|
2005-11-26 |
2006-01-04 |
Medical Res Council |
Healing
|
|
US7943328B1
(en)
|
2006-03-03 |
2011-05-17 |
Prometheus Laboratories Inc. |
Method and system for assisting in diagnosing irritable bowel syndrome
|
|
US20090170772A1
(en)
*
|
2006-03-31 |
2009-07-02 |
Morinaga Milk Industry Co., Ltd. |
Interleukin production regulator, pharmaceutical composition or food comprising the interleukin production regulator, and method for production of the interleukin production regulator
|
|
US20080085524A1
(en)
*
|
2006-08-15 |
2008-04-10 |
Prometheus Laboratories Inc. |
Methods for diagnosing irritable bowel syndrome
|
|
US20100094560A1
(en)
*
|
2006-08-15 |
2010-04-15 |
Prometheus Laboratories Inc. |
Methods for diagnosing irritable bowel syndrome
|
|
US20080118473A1
(en)
*
|
2006-11-01 |
2008-05-22 |
The Procter & Gamble Company |
Methods of treating a respiratory condition comprising probiotic treatment
|
|
ATE521358T1
(de)
*
|
2007-01-17 |
2011-09-15 |
Meiji Co Ltd |
Vorbeugender und/oder therapeutischer wirkstoff zur behandlung einer funktionellen gastrointestinalen erkrankung
|
|
WO2008093303A2
(en)
|
2007-02-01 |
2008-08-07 |
The Iams Company |
Method for decreasing inflammation and stress in a mammal using glucose antimetaboltes, avocado or avocado extracts
|
|
US9408818B2
(en)
*
|
2007-02-28 |
2016-08-09 |
Mead Johnson Nutrition Company |
Method for the utilization of and product containing inactivated probiotic
|
|
NZ580006A
(en)
|
2007-03-28 |
2012-03-30 |
Alimentary Health Ltd |
Probiotic bifidobacterium strain 41387
|
|
US8557233B2
(en)
*
|
2007-03-28 |
2013-10-15 |
Alimentary Heath Limited |
Probiotic bifidobacterium strains
|
|
EP1992351B1
(en)
|
2007-05-18 |
2016-05-11 |
Nestec S.A. |
Lactobacillus johnsonii for prevention of postsurgical infection
|
|
ES2523575T3
(es)
|
2007-06-27 |
2014-11-27 |
Laboratorios Ordesa, S.L. |
Una nueva cepa de bifidobacterium y peptidos acitvos contra infecciones por rotavirus
|
|
EP2065048A1
(en)
*
|
2007-11-30 |
2009-06-03 |
Institut Pasteur |
Use of a L. casei strain, for the preparation of a composition for inhibiting mast cell activation
|
|
ES2343499B1
(es)
*
|
2007-12-24 |
2011-06-10 |
Consejo Superior De Investigaciones Cientificas |
Microorganismos para mejorar el estado de salud de individuos con desordenes relacionados con la ingesta de gluten.
|
|
US9771199B2
(en)
|
2008-07-07 |
2017-09-26 |
Mars, Incorporated |
Probiotic supplement, process for making, and packaging
|
|
US20110189149A1
(en)
*
|
2008-06-20 |
2011-08-04 |
Remy Burcelin |
New Uses of Lactic Acid Bacteria and Bifidobacteria
|
|
EP3181134B1
(en)
*
|
2009-06-19 |
2019-10-30 |
DuPont Nutrition Biosciences ApS |
Bifidobacteria for treating diabetes and related conditions
|
|
US10104903B2
(en)
|
2009-07-31 |
2018-10-23 |
Mars, Incorporated |
Animal food and its appearance
|
|
EP2289527B1
(en)
*
|
2009-08-25 |
2018-02-21 |
Nestec S.A. |
Bifidobacterium longum and functional GI disorders
|
|
EP2485744A4
(en)
*
|
2009-10-09 |
2014-01-22 |
Prothera Inc |
COMPOSITIONS AND METHODS COMPRISING THE PEDIOCOCCUS TO REDUCE AT LEAST ONE SYMPTOM ASSOCIATED WITH DEVELOPMENT-INVASIVE DISORDER IN A PERSON IN WHICH A DEVELOPMENT-INVASIVE DISORDER HAS BEEN DIAGNOSED
|
|
PL2498789T3
(pl)
|
2009-11-11 |
2017-01-31 |
Alimentary Health Limited |
Probiotyczny szczep bifidobacterium
|
|
WO2011148220A1
(en)
|
2010-05-28 |
2011-12-01 |
Compagnie Gervais Danone |
Probiotic strains for use in improving transepithelial resistance
|
|
WO2011148219A1
(en)
|
2010-05-28 |
2011-12-01 |
Compagnie Gervais Danone |
Probiotic strains for use in improving the enteric nervous system
|
|
CA2807242C
(en)
|
2010-08-04 |
2017-05-02 |
Thomas Julius Borody |
Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
|
|
US9011909B2
(en)
|
2010-09-03 |
2015-04-21 |
Wisconsin Pharmacal Company, Llc |
Prebiotic suppositories
|
|
ES2389547B1
(es)
*
|
2010-12-07 |
2013-08-08 |
Consejo Superior De Investigaciones Científicas (Csic) |
Bifidobacterium cect 7765 y su uso en la prevención y/o tratamiento del sobrepeso, la obesidad y patologías asociadas.
|
|
EP2651423B1
(en)
|
2010-12-17 |
2015-09-30 |
Compagnie Gervais Danone |
Lactococcus lactis strains for use in improving digestive condition
|
|
BR112013022927A2
(pt)
|
2011-03-09 |
2016-12-06 |
Univ Minnesota |
composição, métodos para substituir ou suplementar ou modificar uma microbiota do cólon de um sujeito, e para tratar um sujeito, e, uso de uma composição
|
|
CN102899261B
(zh)
*
|
2011-03-11 |
2016-12-07 |
光晟生物科技股份有限公司 |
长双歧杆菌长亚种br022菌株的用途
|
|
GB201112091D0
(en)
|
2011-07-14 |
2011-08-31 |
Gt Biolog Ltd |
Bacterial strains isolated from pigs
|
|
GB201117313D0
(en)
|
2011-10-07 |
2011-11-16 |
Gt Biolog Ltd |
Bacterium for use in medicine
|
|
CN110055320A
(zh)
*
|
2012-03-17 |
2019-07-26 |
加州大学评议会 |
痤疮的快速诊断和个体化治疗
|
|
US9719144B2
(en)
|
2012-05-25 |
2017-08-01 |
Arizona Board Of Regents |
Microbiome markers and therapies for autism spectrum disorders
|
|
GB201306536D0
(en)
|
2013-04-10 |
2013-05-22 |
Gt Biolog Ltd |
Polypeptide and immune modulation
|
|
ITMI20131467A1
(it)
*
|
2013-09-06 |
2015-03-07 |
Sofar Spa |
Uso di una composizione comprendente microrganismi per aumentare la produzione intestinale di acido butirrico, di acido folico o di niacina e/o per diminuire la produzione intestinale di acido succinico
|
|
US20150209468A1
(en)
|
2014-01-24 |
2015-07-30 |
The Procter & Gamble Company |
Hygiene article containing microorganism
|
|
CA2936110A1
(en)
|
2014-01-24 |
2015-07-30 |
The Procter & Gamble Company |
Web comprising a microorganism-containing fibrous element and method for making same
|
|
US20150209392A1
(en)
|
2014-01-24 |
2015-07-30 |
The Procter & Gamble Company |
Filaments Comprising a Microorganism and Method for Making Same
|
|
MA39710A
(fr)
|
2014-04-23 |
2015-10-29 |
Sofar Spa |
Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin
|
|
DK3193901T3
(en)
|
2014-12-23 |
2018-05-28 |
4D Pharma Res Ltd |
PIRIN POLYPEPTIDE AND IMMUNMODULATION
|
|
PE20171138A1
(es)
|
2014-12-23 |
2017-08-09 |
4D Pharma Res Ltd |
Modulacion inmunitaria
|
|
CN114159476A
(zh)
|
2015-05-14 |
2022-03-11 |
克雷斯顿沃控股公司 |
用于粪便菌群移植的组合物以及用于制备和使用它们的方法和用于递送它们的装置
|
|
CN114366759A
(zh)
|
2015-05-22 |
2022-04-19 |
亚利桑那大学董事会 |
用于治疗自闭症谱系障碍及相关症状的方法
|
|
US20160354507A1
(en)
|
2015-06-07 |
2016-12-08 |
The Procter & Gamble Company |
Article of commerce containing absorbent article
|
|
EP3662917A1
(en)
|
2015-06-15 |
2020-06-10 |
4D Pharma Research Limited |
Compositions comprising bacterial strains
|
|
MA41010B1
(fr)
|
2015-06-15 |
2020-01-31 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
|
MA41060B1
(fr)
|
2015-06-15 |
2019-11-29 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
|
PE20180243A1
(es)
|
2015-06-15 |
2018-01-31 |
4D Pharma Res Ltd |
Composiciones que comprenden cepas bacterianas
|
|
LT3360559T
(lt)
|
2015-06-15 |
2019-12-27 |
4D Pharma Research Limited |
Kompozicijos, apimančios bakterijų kamienus
|
|
US20170020750A1
(en)
|
2015-07-23 |
2017-01-26 |
The Procter & Gamble Company |
Patch containing microorganism
|
|
MA41013A
(fr)
|
2015-11-20 |
2017-08-30 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
|
GB201520497D0
(en)
|
2015-11-20 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
|
GB201520638D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
|
GB201520631D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
|
GB201612191D0
(en)
|
2016-07-13 |
2016-08-24 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
|
MX373290B
(es)
|
2016-03-04 |
2020-06-18 |
4D Pharma Plc |
Composiciones que comprenden cepas bacterianas.
|
|
EP3448398A4
(en)
|
2016-04-21 |
2019-12-18 |
Naked Biome, Inc. |
COMPOSITIONS AND METHODS FOR TREATING SKIN DISEASES
|
|
IT201600083376A1
(it)
|
2016-08-08 |
2018-02-08 |
Sofar Spa |
Uso di probiotici per aumentare l’assorbimento proteico
|
|
ITUA20164188A1
(it)
|
2016-06-08 |
2017-12-08 |
Sofar Spa |
Nuovo uso medico di probiotici
|
|
US20170360848A1
(en)
|
2016-06-15 |
2017-12-21 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods for treating autism spectrum disorder and associated symptoms
|
|
US10849936B2
(en)
|
2016-07-01 |
2020-12-01 |
Regents Of The University Of Minnesota |
Compositions and methods for C. difficile treatment
|
|
TWI802545B
(zh)
|
2016-07-13 |
2023-05-21 |
英商4D製藥有限公司 |
包含細菌菌株之組合物
|
|
US20180036352A1
(en)
|
2016-08-03 |
2018-02-08 |
Crestovo Holdings Llc |
Methods for treating ulcerative colitis
|
|
WO2018071537A1
(en)
|
2016-10-11 |
2018-04-19 |
Crestovo Holdings Llc |
Compositions and methods for treating multiple sclerosis and related disorders
|
|
US10092601B2
(en)
|
2016-10-11 |
2018-10-09 |
Crestovo Holdings Llc |
Compositions and methods for treating multiple sclerosis and related disorders
|
|
WO2018071536A1
(en)
|
2016-10-11 |
2018-04-19 |
Crestovo Holdings Llc |
Compositions and methods for treating primary sclerosing cholangitis and related disorders
|
|
IT201600122724A1
(it)
|
2016-12-02 |
2018-06-02 |
Sofar Spa |
Exopolysaccharides and uses thereof
|
|
GB201621123D0
(en)
|
2016-12-12 |
2017-01-25 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
|
IT201600127498A1
(it)
|
2016-12-16 |
2018-06-16 |
Sofar Spa |
Probiotici per uso nella diverticolosi e malattia diverticolare
|
|
EP3589726A1
(en)
|
2017-02-28 |
2020-01-08 |
Alimentary Health Limited |
Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection
|
|
ES2834950T3
(es)
*
|
2017-02-28 |
2021-06-21 |
Prec Group Limited |
Bifidobacterium longum capaz de modular beneficiosamente la respuesta inmunitaria a la infección por virus respiratorio
|
|
EP3606541A1
(en)
|
2017-04-05 |
2020-02-12 |
Crestovo Holdings LLC |
Compositions and methods for treating parkinson's disease (pd) and related disorders
|
|
WO2018187464A1
(en)
|
2017-04-05 |
2018-10-11 |
Crestovo Holdings Llc |
Compositions and methods for treating diverticulitis and related disorders
|
|
MA48940A
(fr)
|
2017-05-22 |
2020-04-08 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
|
MA41708A
(fr)
|
2017-05-24 |
2020-04-08 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
|
CN110996917A
(zh)
|
2017-05-26 |
2020-04-10 |
克雷斯顿沃控股公司 |
包含基于粪便微生物的治疗剂的冻干组合物及其制造和使用方法
|
|
TWI767013B
(zh)
|
2017-06-14 |
2022-06-11 |
英商4D製藥研究有限公司 |
包含細菌品系之組成物
|
|
JP2020523326A
(ja)
|
2017-06-14 |
2020-08-06 |
フォーディー ファーマ リサーチ リミテッド4D Pharma Research Limited |
細菌株を含む組成物
|
|
PL3638271T3
(pl)
|
2017-06-14 |
2021-03-22 |
4D Pharma Research Limited |
Kompozycje zawierające szczepy bakteryjne
|
|
KR102563191B1
(ko)
|
2017-07-05 |
2023-08-02 |
에벨로 바이오사이언시즈, 인크. |
비피도박테리움 애니멀리스 ssp. 락티스를 이용한 암 치료 조성물 및 방법
|
|
KR20200038506A
(ko)
|
2017-08-07 |
2020-04-13 |
핀치 테라퓨틱스, 인코포레이티드 |
건강한 장 장벽을 유지 및 회복시키기 위한 조성물 및 방법
|
|
US20190298783A1
(en)
*
|
2018-03-28 |
2019-10-03 |
Morinaga Milk Industry Co., Ltd. |
Composition for relieving stress, pharmaceutical composition and food and drink composition and method for relieving stress using the composition for relieving stress
|
|
CN108570434A
(zh)
*
|
2018-05-10 |
2018-09-25 |
苏州博悦曼环保科技有限公司 |
高效降解餐厨垃圾的复合菌剂及其制造方法
|
|
US11166990B2
(en)
|
2018-07-13 |
2021-11-09 |
Finch Therapeutics Holdings Llc |
Methods and compositions for treating ulcerative colitis
|
|
CN113164527A
(zh)
|
2018-09-27 |
2021-07-23 |
芬奇治疗控股有限责任公司 |
用于治疗癫痫和相关障碍的组合物和方法
|
|
CN109929773B
(zh)
*
|
2019-01-10 |
2020-06-19 |
江苏德禧生物科技有限公司 |
一株可用于富硒培养的双歧杆菌及其活性蛋白和应用
|
|
CN111411093B
(zh)
*
|
2019-04-30 |
2021-10-22 |
中国科学院天津工业生物技术研究所 |
活性提高的磷酸转酮酶及在生产代谢物中的应用
|
|
WO2021016081A1
(en)
|
2019-07-19 |
2021-01-28 |
Finch Therapeutics Holdings Llc. |
Methods and products for treatment of gastrointestinal disorders
|
|
US11751597B2
(en)
|
2019-11-05 |
2023-09-12 |
Alfasigma S.P.A. |
Compositions comprising bacterial strains for use in increasing the bioavailability of amino acids derived from proteins, and related food product methods and systems
|
|
EP4117697A1
(en)
|
2020-03-13 |
2023-01-18 |
PrecisionBiotics Group Limited |
Bifidobacterium longum
|
|
CN116083327B
(zh)
*
|
2023-04-07 |
2023-06-09 |
天赋能(天津)功能食品研究发展有限公司 |
长双歧杆菌婴儿亚种及在缓解便秘、抗结肠组织炎症和改善肠道菌群方面的应用
|
|
CN116574659A
(zh)
*
|
2023-06-14 |
2023-08-11 |
江南大学 |
一株可缓解类风湿性关节炎的长双歧杆菌婴儿亚种及其应用
|
|
CN119162041A
(zh)
*
|
2024-09-30 |
2024-12-20 |
内蒙古农业大学 |
青春双歧杆菌b-201及其活性物质的后生元制备和应用
|